. Author manuscript; available in PMC: 2020 May 1.

Published in final edited form as: J Pediatr. 2018 Dec 20;208:134–140.e2. doi: 10.1016/j.jpeds.2018.11.043

Table IV.

Adjusted coefficients to predict outcomes

	Change in the percentage of patients experiencing an outcome in response to a 10 percentage point increase in days exposed to furosemide (95% CI)	P-value
BPD	−4.6 percentage points (−7.3, −1.8)	0.001
BPD or death	−3.7 percentage points (−6.6, −0.1)	0.01
Death	0.04 percentage points (−0.24, 0.31)	0.78
	Change in the percentage of patients experiencing an outcome associated with any exposure to furosemide (95% CI)	P-value
BPD	−2.4 percentage points (−12.2, 7.3)	0.62
BPD or death	−1.2 percentage points (−11.1, 8.8)	0.82
Death	2.2 percentage points (−1.3, 5.6)	0.22

BPD, bronchopulmonary dysplasia; CI, confidence interval